Sexually Transmitted Diseases

Limited Risk Compensation Among Women Who Inject Drugs: Results From the Project Sexual Health Equity Preexposure Prophylaxis Demonstration Study in Philadelphia.  49:E64-E66. 2022

Changes in testing and diagnoses of sexually transmitted infections and HIV during the COVID-19 pandemic. 2022

Characteristics of the Audience Reached by the National Network of Sexually Transmitted Disease Clinical Prevention Training Centers and Correlation with Sexually Transmitted Infection Rates, 2015 to 2020.  49:313-317. 2022

A Comparison of Single-Dose Versus Multidose Metronidazole by Select Clinical Factors for the Treatment of Trichomonas vaginalis in Women.  49:231-236. 2022

Association of Bacterial Vaginosis with Higher Vaginal Indole Levels.  49:E53-E55. 2022

Human Immunodeficiency Virus/Sexually Transmitted Infection Testing Preferences for Young Black Men Who Have Sex with Men in the Southeastern United States: Implications for a Post-COVID-19 Era.  49:208-215. 2022

Evaluating the Efficacy of Eradicating Gardnerella vaginalis Vaginal Colonization With Amoxicillin: A Randomized, Double-Blind, Phase 2 Study.  49:133-138. 2022

Report From the National Academies of Sciences, Engineering and Medicine—STI: Adopting a Sexual Health Paradigm—A Synopsis for Sexually Transmitted Infection Practitioners, Clinicians, and Researchers.  49:169-175. 2022

Evaluation of Clinical, Gram Stain, and Microbiological Cure Outcomes in Men Receiving Azithromycin for Acute Nongonococcal Urethritis: Discordant Cures Are Associated with Mycoplasma genitalium Infection.  49:67-75. 2022

Direct-to-Consumer Sexually Transmitted Infection Testing Services: A Position Statement from the American Sexually Transmitted Diseases Association.  48:e155-e159. 2021

Predicting the Probability of Chlamydia Reinfection in African American Women Using Immunologic and Genetic Determinants in a Bayesian Model.  48:813-818. 2021

Tubal Factor Infertility, In Vitro Fertilization, and Racial Disparities: A Retrospective Cohort in Two US Clinics.  48:748-753. 2021

Limited Utility of Reverse Algorithm Syphilis Testing in HIV Clinic among Men Who Have Sex with Men.  48:675-679. 2021

A Systematic Review of New Approaches to Sexually Transmitted Infection Screening Framed in the Capability, Opportunity, Motivation, and Behavior Model of Implementation Science.  48:S58-S65. 2021

Management of Trichomoniasis in the Setting of 5-Nitroimidazole Hypersensitivity.  48:E111-E115. 2021

Prevalence of Chlamydia trachomatis Infection in Young Women and Associated Predictors.  48:529-535. 2021

When Is Any Test Better Than No Test for Chlamydia?.  48:521-522. 2021

Prevalence of and Factors Associated with Genital and Extragenital Chlamydia and Gonorrhea among Transgender Women in HIV Care in the United States, 2005 to 2016.  48:410-416. 2021

The Terms "serofast" and "serological Nonresponse" in the Modern Syphilis Era.  48:451-452. 2021

Clinical Performance of the BD CTGCTV2 Assay for the BD MAX System for Detection of Chlamydia trachomatis, Neisseria gonorrhoeae, and Trichomonas vaginalis Infections.  48:134-140. 2021

Mycoplasma genitalium Infection in Young Women Without Urogenital Symptoms Presenting to a Community-Based Emergency Department in Birmingham, Alabama.  48:e27-e29. 2021

Chlamydia Prevalence by Age and Correlates of Infection among Pregnant Women.  48:37-41. 2021

Factors associated with the recurrence, persistence, and clearance of asymptomatic bacterial vaginosis among young african American women: A repeated-measures latent class analysis.  47:832-839. 2020

Use of a Novel Couples' Verification Tool in a Male Partner Treatment Study of Women with Recurrent Bacterial Vaginosis.  47:E58-E61. 2020

CD4 Trajectory Models and Onset of Non-AIDS-Defining Anal Genital Warts, Precancer, and Cancer in People Living with HIV Infection-1.  47:628-633. 2020

Sexually Transmitted Infection Prevalence among Women at Risk for HIV Exposure Initiating Safer Conception Care in Rural, Southwestern Uganda.  47:E24-E28. 2020

A Narrative Review of Current Challenges in the Diagnosis and Management of Bacterial Vaginosis.  47:441-446. 2020

Cervicitis: Balancing the Goals of Empiric Therapy and Antimicrobial Stewardship to Improve Women's Health.  47:387-388. 2020

Evaluation of the National Sexually Transmitted Disease Curriculum: Reach, Utilization, and Engagement.  47:412-418. 2020

Evaluation of the National Sexually Transmitted Disease Curriculum: Reach, Utilization, and Engagement..  47:412-418. 2020

Highlights From the 2019 HIV Diagnostics Conference: Optimizing Testing for HIV, STIs, and HCV.  47. 2020

Letter From the Guest Editor.  47:S1. 2020

Performance of 4 Molecular Assays for Detection of Chlamydia and Gonorrhea in a Sample of Human Immunodeficiency Virus-Positive Men Who Have Sex With Men..  47:158-161. 2020

Performance of 4 Molecular Assays for Detection of Chlamydia and Gonorrhea in a Sample of Human Immunodeficiency Virus-Positive Men Who Have Sex with Men.  47:158-161. 2020

Identifying Missed Opportunities for Human Immunodeficiency Virus Pre-exposure Prophylaxis During Preventive Care and Reproductive Visits in Adolescents in the Deep South..  47:88-95. 2020

Identifying Missed Opportunities for Human Immunodeficiency Virus Pre-exposure Prophylaxis during Preventive Care and Reproductive Visits in Adolescents in the Deep South.  47:88-95. 2020

Patients Are Willing to Wait for Rapid Sexually Transmitted Infection Results in a University Student Health Clinic.  47:67-69. 2020

Patients Are Willing to Wait for Rapid Sexually Transmitted Infection Results in a University Student Health Clinic..  47:67-69. 2020

Sexually Transmitted Infections in Pregnancy and Reproductive Health: Proceedings of the STAR Sexually Transmitted Infection Clinical Trial Group Programmatic Meeting.  47:5-11. 2020

Pharmacokinetic and Pharmacodynamic Effects of Metronidazole May Account for the Superior Efficacy of Multidose Therapy among Women with Trichomoniasis.  46:751-752. 2019

Mycoplasma genitalium Coinfection in Women With Chlamydia trachomatis Infection.  46:E101-E104. 2019

The National Network of Sexually Transmitted Disease Clinical Prevention Training Centers Turns 40-A Look Back, a Look Ahead.  46:487-492. 2019

The National Network of Sexually Transmitted Disease Clinical Prevention Training Centers Turns 40-A Look Back, a Look Ahead..  46:487-492. 2019

Recent Developments in Biomedical Issues in Sexually Transmitted Infections: Implications for Behavioral Parameters of Interest.  46:E65-E67. 2019

Delay in Seeking Health Care Services After Onset of Urethritis Symptoms in Men..  46:317-320. 2019

Delay in Seeking Health Care Services after Onset of Urethritis Symptoms in Men.  46:317-320. 2019

Efficacy and Safety of Single-Dose Oral Delafloxacin Compared with Intramuscular Ceftriaxone for Uncomplicated Gonorrhea Treatment: An Open-Label, Noninferiority, Phase 3, Multicenter, Randomized Study.  46:279-286. 2019

Is It Time to Stop Using Single-dose Oral Metronidazole for the Treatment of Trichomoniasis in Women?.  46:E57-E59. 2019

Optimal Timing for Trichomonas vaginalis Test of Cure Using Nucleic Acid Amplification Testing.  46:312-316. 2019

Mycoplasma genitalium infections with macrolide and fluoroquinolone resistance-Associated mutations in heterosexual african American couples in Alabama.  46:18-24. 2019

Sexually Transmitted Infection Prevalence in Women with HIV: Is There a Role for Targeted Screening?.  45:762-769. 2018

Mycoplasma genitalium Infection in Kenyan and US Women.  45:514-521. 2018

Defining the Urethritis Syndrome in Men Using Patient Reported Symptoms.  45:e40-e42. 2018

Health Care Provider Perceptions of a Sexually Transmitted Infection Self-testing Program in an HIV Care Clinic.  45:417-421. 2018

Is There a Continuum of Risk for Sexually Transmitted Infections among African American Women?.  45:e20-e22. 2018

Screening for Trichomonas vaginalis in a Large High-Risk Population: Prevalence among Men and Women Determined by Nucleic Acid Amplification Testing.  45:e23-e24. 2018

An exploration of factors impacting preexposure prophylaxis eligibility and access among syringe exchange users.  45:217-221. 2018

The Need to Promote Sexual Health in America: A New Vision for Public Health Action.  44:579-585. 2017

Risk Factors for Incidence of Sexually Transmitted Infections among Women in a Human Immunodeficiency Virus Chemoprevention Trial: VOICE (MTN-003).  44:135-140. 2017

Sexually Transmitted Infections and Human Immunodeficiency Virus: Are We Applying the Lessons Learned?.  44:141-142. 2017

Impact of eligibility criteria on participant enrollment for a randomized clinical trial of gonorrhea treatment.  44:362-364. 2017

Rate of Decline in Nontreponemal Antibody Titers and Seroreversion after Treatment of Early Syphilis.  44:7-11. 2017

Trichomonas vaginalis treated with boric acid in a metronidazole allergic female.  44:120. 2017

Utilization of the Cepheid Xpert® CT/NG Sample Adequacy Control to Determine the Influence of the Urethral Swab on Cellular Content in Post-Swab versus Pre-Swab Urine.  44:68-69. 2017

Genotype-specific concordance of chlamydia trachomatis genital infection within heterosexual partnerships.  43:741-749. 2016

Reducing Missed Opportunities: Pairing Sexually Transmitted Infection Screening with Syringe Exchange Services.  43:706-708. 2016

Azithromycin treatment failure for chlamydia trachomatis among heterosexual men with nongonococcal urethritis.  43:599-602. 2016

Ocular Syphilis in Context.  43:528-529. 2016

Trichomonas vaginalis Nucleic Acid Amplification Testing at an Urban HIV Clinic.  43:483-488. 2016

Variations in Clinical Presentation of Ocular Syphilis: Case Series Reported from a Growing Epidemic in the United States.  43:519-523. 2016

Rapid Diagnosis of Trichomonas vaginalis by Testing Vaginal Swabs in an Isothermal Helicase-Dependent AmpliVue Assay.  43:369-373. 2016

Willingness to disclose sexually transmitted infection status to sex partners among college-aged men in the United States.  43:204-206. 2016

Barriers to bacterial sexually transmitted infection testing of HIV-infected men who have sex with men engaged in HIV primary care.  42:590-594. 2015

Performance of the BD CTQx and GCQx amplified assays on the BD Viper LT compared with the BD viper XTR system.  42:521-523. 2015

Relationship of specific bacteria in the cervical and vaginal microbiotas with cervicitis.  42:475-481. 2015

Comparison of Antimicrobial Susceptibility of Urogenital Neisseria gonorrhoeae Isolates Obtained from Women and Men.  42:434-439. 2015

Generalized Testing for Gonococcal Antibiotic Susceptibility or Sentinel Surveillance.  42:417-418. 2015

Management of Pelvic Inflammatory Disease in Selected US Sexually Transmitted Disease Clinics: Sexually Transmitted Disease Surveillance Network, January 2010-December 2011.  42:429-433. 2015

A phase 3, multicenter, randomized, double-blind, vehicle-controlled study evaluating the safety and efficacy of metronidazole vaginal gel 1.3% in the treatment of bacterial vaginosis.  42:376-381. 2015

Intimate partner violence and correlates with risk behaviors and HIV/STI diagnoses among men who have sex with men and men who have sex with men and women in China: A hidden epidemic.  42:387-392. 2015

It is complicated: Sexual partner characteristic profiles and sexually transmitted infection rates within a predominantly African American population in Mississippi.  42:266-271. 2015

Duration of polymerase Chain reaction-detectable DNA after treatment of Chlamydia trachomatis, Neisseria gonorrhoeae, and Trichomonas vaginalis Infections in Women.  41:215-219. 2014

Azithromycin for rectal chlamydia: Is it time to leave azithromycin on the shelf?..Not yet.  41:86-88. 2014

Preferred methods of sexually transmitted infection service delivery among an urban sample of underserved midwestern men.  41:129-132. 2014

Sexual partnership characteristics of African American women who have sex with women; impact on sexually transmitted infection risk.  41:611-617. 2014

Suspected heterosexual transmission of bacterial vaginosis without seminal fluid exposure.  41:58-60. 2014

Bacterial vaginosis-associated bacteria in men: Association of Leptotrichia/Sneathia spp. with nongonococcal urethritis.  40:944-949. 2013

Sexual history taking and sexually transmitted infection screening in patients initiating erectile dysfunction medication therapy.  40:836-838. 2013

Trichomonas vaginalis in selected US sexually transmitted disease clinics: Testing, screening, and prevalence.  40:865-869. 2013

Bacterial vaginosis among African American women who have sex with women.  40:751-755. 2013

Incident anal human papillomavirus and human papillomavirus-related sequelae in HIV-infected versus HIV-uninfected adolescents in the United States.  40:715-720. 2013

Intravaginal metronidazole/miconazole for the treatment of vaginal trichomoniasis.  40:710-714. 2013

A prospective cohort study comparing the effect of single-dose 2 G metronidazole on trichomonas vaginalis infection in HIV-seropositive versus HIV-seronegative women.  40:499-505. 2013

Is there evidence of the new variant chlamydia trachomatis in the United States?.  40:352-353. 2013

Prevalence and treatment outcome of cervicitis of unknown etiology.  40:379-385. 2013

Sexual behaviors, perception of sexually transmitted infection risk, and practice of safe sex among southern african american women who have sex with women.  40:395-400. 2013

American sexually transmitted diseases association and the thomas parran award: Past, present, and future.  40:275-276. 2013

Chlamydia trachomatis infection among women 26 to 39 years of age in the united states, 1999 to 2010.  40:335-337. 2013

Remembering thomas parran, his contributions and missteps going forward: History informs us.  40:281-282. 2013

Vaginal swabs are the optimal specimen for detection of genital chlamydia trachomatis or neisseria gonorrhoeae using the cobas 4800 CT/NG test.  40:247-250. 2013

Predictors of undiagnosed herpes simplex virus type 2 seropositivity among persons attending an HIV care clinic.  39:857-859. 2012

Prevalence of the 23S rRNA A2058G point mutation and molecular subtypes in treponema pallidum in the United States, 2007 to 2009.  39:794-798. 2012

Rapid plasma reagin titer variation in the 2 weeks after syphilis therapy.  39:645-647. 2012

The posttrial effect of oral periodic presumptive treatment for vaginal infections on the incidence of bacterial vaginosis and lactobacillus colonization.  39:361-365. 2012

Incidence, prevalence, and epidemiology of herpes simplex virus-2 in HIV-1-positive and HIV-1-negative adolescents.  39:300-305. 2012

Clinical evaluation of the BD ProbeTec ^™ Neisseria gonorrhoeae Q ^x Amplified DNA Assay on the BD Viper ^™ System with XTR™ Technology.  39:147-153. 2012

Evaluation of the Roche cobas® CT/NG test for detection of Chlamydia trachomatis and Neisseria gonorrhoeae in male urine..  39:543-549. 2012

Genotypic characterization of Trichomonas vaginalis isolates among women who have sex with women in sexual partnerships..  39:556-558. 2012

HPV vaccine implementation in STD clinics-STD surveillance network.  39:32-34. 2012

Effect of sexual activity on vaginal colonization with hydrogen peroxide-producing lactobacilli and gardnerella vaginalis.  38:1137-1144. 2011

Sexually transmitted infections and risk behaviors among African American women who have sex with women: Does sex with men make a difference?.  38:1118-1125. 2011

Antimicrobial resistant gonorrhea in Atlanta: 1988-2006.  38:780-782. 2011

The natural history of incident gonococcal infection in adolescent women.  38:750-754. 2011

Assessing male condom failure and incorrect use.  38:580-586. 2011

Clinical evaluation of the BD probetec™ chlamydia trachomatis Qx amplified DNA assay on the BD viper™ system with XTR™ technology.  38:603-609. 2011

Prevalence of bacterial vaginosis and vulvovaginal candidiasis mixed infection in a southeastern American STD clinic.  38:672-674. 2011

Characteristics of women reporting multiple recent sex partners presenting to a sexually transmitted disease clinic for care.  38:210-215. 2011

Changing sexually transmitted infection screening protocol will result in improved case finding for trichomonas vaginalis among high-risk female populations.  38:398-400. 2011

Bacterial vaginosis: Identifying research gaps proceedings of a workshop sponsored by DHHS/NIH/NIAID.  37:732-744. 2010

Epidemiological synergy of trichomonas vaginalis and HIV in Zimbabwean and South African women.  37:460-466. 2010

Even NHANES evolves: Some surprising findings about women who have sex with women.  37:414-415. 2010

A randomized controlled trial of partner notification methods for prevention of trichomoniasis in women.  37:392-396. 2010

Prevalence and risks for bacterial vaginosis in women who have sex with women.  37:335-339. 2010

Spontaneous resolution of extragenital chlamydial and gonococcal infections prior to therapy.  37:343-344. 2010

Walter E. Stamm, MD, 1945-2009.  37:281-282. 2010

Herpes simplex virus in African American heterosexual males: The roles of age and male circumcision.  37:217-222. 2010

Race of male sex partners and occurrence of bacterial vaginosis.  37:184-190. 2010

Personal hygienic behaviors and bacterial vaginosis.  37:94-99. 2010

Concordance of rectal and cervical chlamydia trachomatis OmpA genotypes infecting women in Birmingham, Alabama.  37:32-33. 2010

Evaluation of azithromycin resistance in Treponema pallidum specimens from madagascar.  36:775-776. 2009

Implementation of routine access to herpes simplex virus type 2 antibody testing in a public health sexually transmitted disease clinic.  36:724-728. 2009

Disentangling contributions of reproductive tract infections to hiv acquisition in african women.  36:357-364. 2009

Upstairs and downstairs socio-economic and gender interactions in herpes simplex virus type 2 seroprevalence in australia.  36:344-349. 2009

A 15-Minute interactive, computerized condom use intervention with biological endpoints.  36:73-78. 2009

Prevalence of gardnerella vaginalis in male sexual partners of women with and without bacterial vaginosis.  36:92-94. 2009

The association between oral contraceptives, depot-medroxyprogesterone acetate, and trichomoniasis.  36:336-340. 2009

Absence of lymphogranuloma venereum strains among rectal Chlamydia trachomatis outer membrane protein a genotypes infecting women and men who have sex with men in Birmingham, Alabama.  35:856-858. 2008

Sexual risk behaviors and sexually transmitted infection prevalence in an outpatient psychiatry clinic.  35:877-882. 2008

Chlamydia positivity in american Indian/Alaska native women screened in family planning clinics, 1997-2004.  35:753-757. 2008

Immunogenetic correlates of neisseria gonorrhoeae infection in adolescents.  35:656-661. 2008

Risk factors for incident herpes simplex type 2 virus infection among women attending a sexually transmitted disease clinic.  35:679-685. 2008

Association of mobiluncus curtisii with recurrence of bacterial vaginosis.  35:611-613. 2008

Chlamydia prevalence among college students: Reproductive and public health implications.  35:529-532. 2008

Influence of sexual activity on cytomegalovirus seroprevalence in the United States, 1988-1994.  35:472-479. 2008

Chlamydia antibodies, chlamydia heat shock protein, and adverse sequelae after pelvic inflammatory disease: The PID Evaluation and Clinical Health (PEACH) Study.  35:129-135. 2008

The natural history of untreated Chlamydia trachomatis infection in the interval between screening and returning for treatment.  35:119-123. 2008

Acceptability of urine-based screening for Chlamydia trachomatis in asymptomatic young men: a systematic review..  35. 2008

Chlamydia trachomatis positivity rates among men tested in selected venues in the United States: a review of the recent literature..  35. 2008

Neonatal herpes - The forgotten perinatal infection.  35:22-24. 2008

The cost-effectiveness of screening men for Chlamydia trachomatis: a review of the literature..  35. 2008

The program cost and cost-effectiveness of screening men for Chlamydia to prevent pelvic inflammatory disease in women..  35. 2008

Longitudinal association between hormonal contraceptives and bacterial vaginosis in women of reproductive age.  34:954-959. 2007

Natural history of asymptomatic bacterial vaginosis in a high-risk group of women.  34:876-877. 2007

Population-based outreach for chlamydia screening in men: Results from a randomized trial.  34:837-839. 2007

Within the hidden epidemic: Sexually transmitted diseases and HIV/AIDS among American Indians and Alaska natives.  34:767-777. 2007

Incidence of neonatal herpes simplex virus infections in a managed-care population.  34:704-708. 2007

Self-reported mechanical problems during condom use and semen exposure: Comparison of two randomized trials in the United States of America and Brazil.  34:557-562. 2007

Pelvic examination findings and chlamydia trachomatis infection in asymptomatic young women screened with a nucleic acid amplification test.  34:335-338. 2007

Acceptability of urine-based screening for Chlamydia trachomatis to asymptomatic young men and their providers.  34:147-153. 2007

Superficial hepatic capsular lesions in a systemically ill young woman.  34:139-140. 2007

Sexually transmitted infections and risk factors among truck stand workers in Dhaka, Bangladesh.  34:99-103. 2007

Sexually transmitted infections among urban shelter clients.  33:666-669. 2006

A pilot study of vaginal flora changes with randomization to cessation of douching.  33:610-613. 2006

Association of Chlamydia trachomatis serovar Ia infection with black race in a sexually transmitted diseases clinic patient population in Birmingham, Alabama.  33:621-624. 2006

Health insurance coverage, health care-seeking behaviors, and genital chlamydial infection prevalence in sexually active young adults.  33:389-396. 2006

The impact of natural history parameters on the cost-effectiveness of Chlamydia trachomatis screening strategies.  33:428-436. 2006

Prevalence of Neisseria gonorrhoeae among men screened for Chlamydia trachomatis in four United States Cities, 1999-2003.  33:314-319. 2006

Vaginal douche practices among black women at risk: Exploring douching prevalence, reasons for douching, and sexually transmitted disease infection.  33:215-219. 2006

Chlamydial infections among female adolescents screened in juvenile detention centers in Washington State, 1998-2002.  33:63-67. 2006

An intervention to reduce vaginal douching among adolescent and young adult women: A randomized, controlled trial.  32:752-758. 2005

Vaginal swabs are the specimens of choice when screening for Chlamydia trachomatis and Neisseria gonorrhoeae: Results from a multicenter evaluation of the APTIMA assays for both infections.  32:725-728. 2005

Women find it easy and prefer to collect their own vaginal swabs to diagnose Chlamydia trachomatis or Neisseria gonorrhoeae infections.  32:729-733. 2005

A randomized trial of clinician-delivered interventions promoting barrier contraception for sexually transmitted disease prevention.  32:672-679. 2005

Risk factors for bacterial vaginosis in women at high risk for sexually transmitted diseases.  32:654-658. 2005

Chlamydial and gonococcal infection in men without polymorphonuclear leukocytes on gram stain: Implications for diagnostic approach and management.  32:630-634. 2005

Dangerous assumptions: Lesbians and sexual death.  32:570-571. 2005

Neonatal herpes should be a reportable disease.  32:521-525. 2005

Bacterial vaginosis (BV) and the risk of incident gonococcal or chlamydial genital infection in a predominantly black population.  32:413-417. 2005

The cost effectiveness of gonorrhea screening in urban emergency departments.  32:425-436. 2005

Chlamydia screening of at-risk young women in managed health care: Characteristics of top-performing primary care offices.  32:382-386. 2005

Prevalence of Chlamydia trachomatis infection among men screened in 4 U.S. cities.  32:74-77. 2005

Female condom and male condom failure among women at high risk of sexually transmitted diseases.  32:35-43. 2005

Sexually transmitted disease/HIV transmission risk behaviors and sexually transmitted disease prevalence among HIV-positive men receiving continuing care.  32:20-26. 2005

Predictors of bacterial vaginosis in adolescent women who douche.  31:433-436. 2004

Vaginal lactobacilli in adolescents: Presence and relationship to local and systemic immunity, and to bacterial vaginosis.  31:393-400. 2004

Re-evaluating Selective Screening Criteria for Chlamydial Infection among Women in the U.S. Pacific Northwest.  31:283-289. 2004

The Effect of Urine Testing in Evaluations of the Sensitivity of the Gen-Probe APTIMA® Combo 2 Assay on Endocervical Swabs for Chlamydia trachomatis and Neisseria gonorrhoeae: The Infected Patient Standard Reduces Sensitivity of Single Site Evaluation.  31:273-277. 2004

A Randomized, Double-Blind Clinical Trial of Vaginal Acidification versus Placebo for the Treatment of Symptomatic Bacterial Vaginosis.  31:236-238. 2004

Risk-Taking and Health-Seeking Behavior in Men with a History of Urethritis: Is There a Learning Curve?.  31:225-228. 2004

Prevalence and Risk Factors for Infection with Herpes Simplex Virus Type-1 and -2 among Lesbians.  30:890-895. 2003

Acceptability of Urine Screening for Neisseria gonorrheae and Chlamydia trachomatis in Adolescents at an Urban Emergency Department.  30:850-853. 2003

Early onset of vaginal douching is associated with false beliefs and high-risk behavior.  30:689-693. 2003

Comparison of STD burden and risk among men with and without regular doctors attending a southern urban STD clinic.  30:512-515. 2003

A refined estimate of the average lifetime cost of pelvic inflammatory disease.  30:369-378. 2003

Prevalence and factors associated with gonorrhea and chlamydial infection in at-risk females presenting to an urban emergency department.  30:335-339. 2003

The clinical and economic consequences of screening young men for genital chlamydial infection.  30:99-106. 2003

The relationship of serovar to clinical manifestations of urogenital Chlamydia trachomatis infection.  30:160-165. 2003

Demonstration of declining community prevalence of Chlamydia trachomatis infection using sentinel surveillance.  30:20-24. 2003

Why women douche and why they may or may not stop.  30:71-74. 2003

Findings from STD screening of adolescents and adults entering corrections facilities: Implications for STD control strategies.  29:834-839. 2002

Projection of the future dimensions and costs of the genital herpes simplex type 2 epidemic in the United States.  29:608-622. 2002

Association of adolescents' history of sexually transmitted disease (STD) and their current high-risk behavior and STD status: A case for intensifying clinic-based prevention efforts.  29:503-509. 2002

Sexual behavior of international travelers visiting Peru.  29:510-513. 2002

A randomized, comparative pilot study of azithromycin versus benzathine penicillin G for treatment of early syphilis.  29:486-490. 2002

Associations between biologically confirmed marijuana use and laboratory-confirmed sexually transmitted diseases among African American adolescent females.  29:387-390. 2002

Epidemiology of anorectal chlamydial and gonococcal infections among men having sex with men in Seattle: Utilizing serovar and auxotype strain typing.  29:189-195. 2002

Interrelationships of bacterial vaginosis and cervical inflammation.  29:59-64. 2002

Screening women in jails for chlamydial and gonococcal infection using urine tests feasibility, acceptability, prevalence, and treatment rates.  29:271-276. 2002

Sexual risk behaviors associated with having older sex partners: A study of black adolescent females.  29:20-24. 2002

Erratum: The relative increase in prevalence using LCR was highest among men with < 5 polymorphonuclear leukocytes per high-power (1000×) field (PMN/HPF) on urethral Gram stain regardless of symptoms, and in symptomatic men with gonorrhea diagnosed by urethral culture (Sexually Transmitted Diseases 28:4 (220)).  28:429. 2001

Condom carrying is not associated with condom use and lower prevalence of sexually transmitted diseases among minority adolescent females.  28:444-447. 2001

Modification of syphilitic genital ulcer manifestations by coexistent HIV infection.  28:448-454. 2001

Motorcycle taxi drivers and sexually transmitted infections in a Peruvian Amazon city.  28:11-13. 2001

Prevalence of Mobiluncus spp among women with and without bacterial vaginosis as detected by polymerase chain reaction.  28:195-199. 2001

Psychosocial correlates of adolescents' worry about STD versus HIV infection: Similarities and differences.  28:208-213. 2001

Single-dose gatifloxacin compared with ofloxacin for the treatment of uncomplicated gonorrhea: A randomized, double-blind, multicenter trial.  28:136-142. 2001

Socioeconomic status and self-reported gonorrhea among African American female adolescents.  28:236-239. 2001

Urine-based screening for Chlamydia trachomatis in men attending sexually transmitted disease clinics.  28:219-225. 2001

Validity of self-reported sexually transmitted diseases among african american female adolescents participating in an HIV/STD prevention intervention trial.  28:468-471. 2001

High prevalence of asymptomatic STDs in incarcerated minority male youth: A case for screening.  27:175-177. 2000

Seroprevalence and risk factors of hepatitis B, hepatitis C, and human cytomegalovirus among HIV-infected and high-risk uninfected adolescents: Findings of the reach study.  27:296-303. 2000

Practice patterns for the elicitation of sexual history, education, and counseling among providers of STD services: Results from the gonorrhea community action project (GCAP).  26:584-589. 1999

Double-blind comparison of trovafloxacin and doxycycline in the treatment of uncomplicated chlamydial urethritis and cervicitis.  26:531-536. 1999

Patterns of Chlamydia trachomatis testing and follow-up at a University Hospital Medical Center.  26:496-499. 1999

Trichomonas vaginalis - No longer a minor STD.  26:388-389. 1999

Correlates of herpes simplex virus seroprevalence among women attending a sexually transmitted disease clinic.  26:329-334. 1999

Self-reported sexual activity and condom use among symptomatic clients attending STD clinics.  26:286-290. 1999

Prevalence of gonococcal and chlamydial infections in commercial sex workers in a Peruvian Amazon City.  26:103-107. 1999

Under the influence: Risky sexual behavior and substance abuse among driving under the influence offenders.  26:87-92. 1999

Determinants of reinfection with Chlamydia trachomatis.  26:4-11. 1999

Measured versus self-reported compliance with doxycycline therapy for chlamydia-associated syndromes: High therapeutic success rates despite poor compliance.  26:272-280. 1999

Mechanical failure of the latex condom in a cohort of women at high STD risk.  26:450-458. 1999

Prospective study of barrier contraception for the prevention of sexually transmitted diseases: Study design and general characteristics of the study group.  26:127-136. 1999

The rapid test paradox: When fewer cases detected lead to more cases treated: A decision analysis of tests for Chlamydia trachomatis.  26:232-240. 1999

Objective markers of condom failure.  25:427-432. 1998

Compliance with doxycycline therapy in sexually transmitted diseases clinics.  25:1-4. 1998

Patients attending STD clinics in an evolving health care environment: Demographics, insurance coverage, preferences for STD services, and STD morbidity.  24:599-605. 1997

Delayed presentation to clinics for sexually transmitted diseases by symptomatic patients: A potential contributor to continuing STD morbidity.  24:443-448. 1997

Definitions of genital ulcer disease and variation in risk for prevalent human immunodeficiency virus infection.  24:436-442. 1997

Self- treatment patterns among clients attending sexually transmitted disease clinics and the effect of self-treatment on STD symptom duration.  24:372-377. 1997

Performance and cost-effectiveness of selective screening criteria for Chlamydia trachomatis infection in women: Implications for a national chlamydia control strategy.  24:131-141. 1997

Positive screening tests for gonorrhea and chlamydial infection fail to lead consistently to treatment of patients attending a sexually transmitted disease clinic.  24:181-184. 1997

Spontaneous clearance of chlamydia trachomatis infection in untreated patients.  24:229-235. 1997

The use of sequential self-obtained vaginal smears for detecting changes in the vaginal flora.  24:236-239. 1997

Biomedical issues in syphilis control.  23:5-8. 1996

Declining prevalence of chlamydial infection among adolescent girls.  23:226-229. 1996

Therapeutic efficacy and complications of excisional biopsy of condyloma acuminatum.  23:273-276. 1996

Tuberculosis screening in a sexually transmitted diseases clinic.  23:299-303. 1996

Condom use to prevent incident stds: The validity of self-reported condom use.  22:15-21. 1995

Laboratory to laboratory variation in chlamydia trachomatis culture practices.  22:322-326. 1995

Metronidazole: Utilization in the obstetric and gynecologic patient.  22:370-376. 1995

Development of sexually transmitted diseases treatment guidelines, 1993. New methods, recommendations, and research priorities. STD Treatment Guidelines Project Team and Consultants..  21:S96-101. 1994

Alcohol and other substance use in std clinic patients: Relationships with stds and prevalent hiv infection.  21:220-225. 1994

Characterization of patients accepting and refusing routine, voluntary hiv antibody testing in public sexually transmitted disease clinics.  21:31-35. 1994

Efficacy of 250 mg trospectomycin sulfate im vs. 250 mg ceftriaxone im for treatment of uncomplicated gonorrhea.  21:213-216. 1994

Routine serologic screening for syphilis in hospitalized patients: High prevalence of unsuspected infection in the elderly.  21:133-136. 1994

Chlamydial infection and sexual behavior in young pregnant teenagers.  20:45-50. 1993

Multicenter, comparative study of cefotaxime and ceftriaxone for treatment of uncomplicated gonorrhea.  20:269-273. 1993

Disease prevalence among women attending a sexually transmitted disease clinic varies with reason for visit.  19:88-91. 1992

Gene typing of chlamydia trachomatis by polymerase chain reaction and restriction endonuclease digestion.  19:303-308. 1992

Nonculture tests for genital tract chlamydial infection: What does the package insert mean, and will it mean the same thing tomorrow?.  19:243-244. 1992

Prevalence and patterns of condom use among patients attending a sexually transmitted disease clinic.  19:175-180. 1992

Prevalence and patterns of condom use among patients attending a sexually transmitted disease clinic.  19:175-180. 1992

Temporal trends in gonococcal antibiotic resistance in baltimore.  19:213-218. 1992

Genital human papillomavirus infections in patients attending an inner-city STD clinic..  18:183-187. 1991

Surrogate methods to diagnose gonococcal and chlamydial cervicitis: Comparison of leukocyte esterase dipstick, endocervical gram stain, and culture.  18:211-216. 1991

Behavioral relapse among homosexually active men: Implications for std control.  17:161-162. 1990

Evaluation of abbott test pack® chlamydia for detection of chlamydia trachomatis in patients attending sexually transmitteddiseases clinics.  17:147-151. 1990

Reproductive health practices in women attending an inner-city std clinic.  17:133-137. 1990

Routine voluntary hiv screening in std clinic clients: Characterization of infected clients.  17:211-215. 1990

Routine voluntary hiv screening in std clinic clients: Characterization of infected clients.  17:211-215. 1990

Trends in sexually transmitted diseases in homosexually active men in king county, washington, 1980–1990.  17:211-215. 1990

Multicenter, comparative study of enoxacin and ceftriaxone for treatment of uncomplicated gonorrhea.  16:148-151. 1989

Auxotype/serovar diversity and antimicrobial resistance of neisseria gonorrhoeae in two mid-sized american cities.  14:141-146. 1987

Ceftriaxone for treatment of uncomplicated gonorrhea: Routine use of a single 125-mg dose in a sexually transmitted disease clinic.  14:227-230. 1987

Detection of treponema pallidum by a fluorescent monoclonal antibody test.  14:156-159. 1987

Epidemiology of gonorrhea: Distribution and temporal changes in auxotype/serovar classes of neisseria gonorrhoeae.  14:26-32. 1987

Ceftriaxone therapy for asymptomatic neurosyphilis. Case report and Western blot analysis of serum and cerebrospinal fluid IgG response to therapy..  13:185-188. 1986

Analysis of dna from recurrent genital herpes simplex virus isolates by restriction endonuclease digestion.  13:61-66. 1986

Ceftriaxone therapy for asymptomatic neurosyphilis: Case report and western blot analysis of serum and cerebrospinal fluid IgG response to therapy.  13:185-188. 1986

Serogrouping of neisseria gonorrhoeae: Correlation of serogroup with disseminated gonococcal infection.  11:77-80. 1984

Isolation of Mycoplasma hominis and Ureaplasma urealyticum from amniotic fluid at 16-20 weeks of gestation: potential effect on outcome of pregnancy..  10:294-302. 1983

Antigens of mycoplasma hominis.  10:247-255. 1983

Isolation of mycoplasma hominis and ureaplasma urealyticum from amniotic fluid at 16-20 weeks of gestation: Potential effect on outcome of pregnancy.  10:294-302. 1983